摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

heptadecafluoro-1-azabicyclo<5,3,0>decane | 84818-81-5

中文名称
——
中文别名
——
英文名称
heptadecafluoro-1-azabicyclo<5,3,0>decane
英文别名
perfluoro-1-azabicyclo(5,3,0)decane;heptadecafluoro-1-azabicyclo[5,3,0]decane;Heptadecafluoro-1-azabicyclo[5.3.0]decane;1,1,2,2,3,3,5,5,6,6,7,7,8,8,9,9,9a-heptadecafluoropyrrolo[1,2-a]azepine
heptadecafluoro-1-azabicyclo<5,3,0>decane化学式
CAS
84818-81-5
化学式
C9F17N
mdl
——
分子量
445.079
InChiKey
VSWNBIICUATMJH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    128-129 °C
  • 密度:
    1.88±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    27
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    18

SDS

SDS:d00ae24a41685bb34b99b5ee2550301d
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Fluorinations with complex metal fluorides Part 8. Ring rearrangement in the fluorinations of quinoline with caesium tetrafluorocobaltate and with cobalt(III) fluoride
    作者:Raymond G. Plevey、Richard W. Rendell、John Colin Tatlow
    DOI:10.1016/s0022-1139(00)81454-2
    日期:1982.12
    similarly, but the only new product isolated was tridecafluoro-3-azabicyclo[4,4,0]deca- 1(6)-2-diene (R). The rearrangement occurring with quinoline prompted a re-examination of its fluorination by cobalt(III) fluoride. At ca. 350°, compound F was the major product, with very little E: there were some ring-opened materials, the most important being tetradecafluoro-4-pentafluoroethyl- 2-azaoct-2(Z)-ene (N)
    在约350°时对喹啉进行化,主要得到五-2-氮杂双环[4,4,0] dec-1(2)-烯(E)和七-1-杂氮杂双[5,3]的混合物,0]由骨架重排产生的癸烷(F)。次要产物为六个多环己[b]-吡啶(GL),所有碳环均具有-(CF 2)4-部分。化合物F无反应性,但E对亲核试剂(例如甲醇)高度敏感。异喹啉类似地被化,但是分离出的唯一新产物是十三-3-氮杂双环[4,4,0]十-1(6)-2-二烯(R)。喹啉发生重排促使(III)重新检查了其化程度。在约350°时,化合物F是主要产物,而E却很少:有一些开环的材料,最重要的是十四-4-五乙基-2-氮杂辛2(Z)-烯(N)。
  • Fluorinated polycyclic compounds
    申请人:ISC CHEMICALS LIMITED
    公开号:EP0368561A2
    公开(公告)日:1990-05-16
    A fully fluorinated and fully-saturated heterocyclic organic compound of general formula wherein the saturated rings F are fully fluorinated, and where the Rf radical is selected from perfluoro-alkyl groups, perfluoro-alicyclic groups, and mixed perfluoro-cycloalkyl-alkyl groups, and wherein the Rf radical contains from 1 to 10 carbon atoms inclusive.
    通式为全氟全饱和杂环有机化合物 其中饱和环 F 为全氟化,Rf 基选自全氟烷基、全氟脂环基和全氟环烷基-烷基混合基团,Rf 基含有 1 至 10 个碳原子(含 10 个)。
  • TATLOW, J. C.;PLEVEY, R. G.;WOTTON, D. E. M.;SARGENT, C. R.
    作者:TATLOW, J. C.、PLEVEY, R. G.、WOTTON, D. E. M.、SARGENT, C. R.
    DOI:——
    日期:——
  • US4562183A
    申请人:——
    公开号:US4562183A
    公开(公告)日:1985-12-31
  • US4935524A
    申请人:——
    公开号:US4935524A
    公开(公告)日:1990-06-19
查看更多

同类化合物

顺式-2-BOC-八氢-吡咯并[3,4-D]氮杂庚烷 羟甲磺酸二甲磺酸 环戊二烯并[4,5]氮杂卓并[2,1,7-cd]吡咯里嗪 四氢-1H-吡咯并[1,2-a]氮杂卓-3,9(2H,9aH)-二酮 吡咯并[1,2-a]氮杂-5-酮 吖庚英并[4,3-b]吲哚-1(2H)-酮,7-氟-3,4,5,6-四氢-6-甲基- 六氢-1H-吡咯并[1,2-A]氮杂卓-5(6H)-酮 N,N-二甲基-3-(3-甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)丙-1-胺 9-氟-3,4-二氢-1H-吡啶并[4,3-B]吲哚-2(5H)-羧酸叔丁酯 9-氟-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 7,8-二氢-5H-吡咯并[1,2-A]氮杂环庚烷-9(6H)-酮 6-叔-丁基3A-乙基八氢吡咯并[2,3-D]氮杂卓-3A,6(2H)-二甲酸基酯 6,7-二氢吡咯并[2,3-c]氮杂卓-4,8(1H,5H)-二酮 5H-吡咯并[1,2-a]氮杂卓-7-醇 5,9:7,11-二亚甲基-5H-吡咯并[1,2-a]吖壬英-3-羧酸,6,7,8,9,10,11-六氢-,甲基酯 4-(2-氨基-1H-咪唑-5-基)-2,3-二溴-6,7-二氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1H-咪唑-4-基)-2,3-二溴-4,5,6,7-四氢吡咯并[2,3-c]氮杂卓-8(1H)-酮 4-(2-氨基-1,5-二氢-5-氧代-4H-咪唑-4-亚基)-4,5,6,7-四氢-吡咯并[2,3-c]氮杂卓-8(1H)-酮 3-苄基-1,2,3,4,5,6-六氢氮杂卓并[4,5-b]吲哚 3-(3,9-二甲基-1,2,4,5-四氢氮杂卓并[4,5-b]吲哚-6-基)-N,N-二甲基丙烷-1-胺 2H,3H-氧杂环丁烷并[3,2-d]吡咯并[1,2-a]氮杂卓 2-碘-1,5,6,7-四氢-4H-吡咯并[3,2-C]吡啶-4-酮 2-溴-6,7-二氢-1h,5h-吡咯并[2,3-c]氮杂烷-4,8-二酮 2-溴-5,6,7,8-四氢吡咯并[3,2-C]氮杂庚烷-4(1H)-酮 2,5-已炔二醇 2,3,4,5-四氢-N,N-二甲基-2-(3,4,5-三甲氧基苯甲酰基)-氮杂卓并(3,4-b)吲哚-10(1H)-丙胺 11-氧杂-3,10-二氮杂三环[7.2.1.03,7]十二碳-1,4,6,9-四烯 1-苄基-八氢-吡咯并[3,4-b]吡啶 1,4,5,6,7,8-六氢吡咯并[3,2-b]氮杂卓 1,2,3,4,5,6-六氢氮杂环庚烷[4,3-B]吲哚盐酸盐 1,2,3,4,5,6-六氢-9-甲基氮杂卓并[4,5-b]吲哚 1,2,3,4,5,6-六氢-6-甲基氮杂革[4,5-b]吲哚盐酸盐 1,2,3,4,5,6-六氢-3-甲基氮杂卓并[4,5-b]吲哚 4-acetoxy-5,18-seco-20,21-dinor-ibogamine 3-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)-1-(1-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)ethylidene)-1H-isoindole (7S,10R)-2-methyl-5-[(Z)-2-(6-methylpyridin-3-yl)vinyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole 6-[(6-chloropyridin-3-yl)methyl]-9-fluoro-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole (2S,3S)-tartrate 6-[(Z)-2-(6-methylpyridin-3-yl)vinyl]-9-(trifluoromethoxy)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 6-[2-(6-methylpiperidin-3-yl)ethyl]-9-(trifluoromethoxy)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 9-methyl-6-[(Z)-2-pyridin-3-ylvinyl]-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 8-methyl-5,15-dihydro-6H-naphtho[2',3':1,2]indolizino[8,7-b]indole-9,14-dione 4-methyl-2-(trimethylsilyl)methylsulfanyl-1-azabicyclo[5.3.0]deca-2,7,9-triene 1-(N-Methyl-2-piperidyl)cyclohexan-carbonsaeureethylester 2-methyl-1,2,3,4,5,6,7,8-octahydro-2,5-indolodiazocine 9-methyl-6-[2-(2-methylphenyl)ethyl]-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 6-[(E)-2-pyridin-3-ylvinyl]-9-(trifluoromethoxy)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 6-[(Z)-2-(6-methylpyridin-3-yl)vinyl]-9-(methylsulfonyl)-3,4,5,6-tetrahydro-1H-2,5-ethanoazepino[4,3-b]indole 16α-Hydroxy-21-oxo-20ξ-dihydro-cleavamin 3-benzyl-9-methoxy-1,2,3,4,5,6-hexahydro-azepino[4,5-b]indole-8-carbaldehyde tert-butyl 3,4,5,10-tetrahydroazepino[3,4-b]indole-2(1H)-carboxylate